Announced Mon, 12 Oct, 2026 · 15:52 IST
Routine share demat certificate filed for Q2 FY27
SOTAC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Sotac Pharmaceuticals has filed a routine compliance certificate from its registrar Kfin Technologies under SEBI Regulation 74(5). The certificate confirms that no requests for converting physical shares into electronic form or vice versa were received between July and September 2026. This is a standard quarterly filing required of all listed companies to confirm share transfer and demat activity status.
Likely market impact
No impact on shareholders. This is a routine procedural filing with no financial or operational significance.